Business

The More Life Company Reports Rapid Systemic Delivery of USP Testosterone in Exploratory Quicksome™ Study

Financial Post · September 22, 2026 at 8:59 a.m.

Eight-participant pharmacokinetic study shows rapid systemic appearance following administration of 5 mg and 15 mg Quicksome™ sublingual formulations TORONTO — The More Life Company Corp. (the “Company” or “MLCO”), (CSE:

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

The More Life Company Reports Rapid Systemic Delivery of USP Testosterone in Exploratory Quicksome™ Study

More from Financial Post

Flame collected in Turin as Changchun prepares to welcome 2027 Winter Universiade

PALESTINIAN REFORM ADVOCATE SAMER SINIJLAWI TELLS THE NEWS FORUM: ‘88% of eligible Palestinian voters have already preregistered for the November 28th election — the first election since 2005’

ModelFront Announces OpenLoc, the Open TMS Built for AI

PRU Quarterly Report Investor Webinar

More in Business

Canada can't launch rockets on its own. A handful of companies want to change that

Flame collected in Turin as Changchun prepares to welcome 2027 Winter Universiade

PALESTINIAN REFORM ADVOCATE SAMER SINIJLAWI TELLS THE NEWS FORUM: ‘88% of eligible Palestinian voters have already preregistered for the November 28th election — the first election since 2005’

ModelFront Announces OpenLoc, the Open TMS Built for AI

PRU Quarterly Report Investor Webinar

EasyPark Receives Three Awards at Canadian Parking Association Conference